Colgate-Palmolive Company
CL Consumer Defensive Household & Personal Products NYSE
$85.29
$-1.37 (-1.58%)
Open: $86.67 | High: $86.89 | Low: $85.21 | Prev Close: $86.66
Market Cap: $68.75B
Volume: 3.2M | Avg: 6.9M
Last updated: January 26, 2026 at 06:01 PMInvestment Rating
Neutral
Overall Score: 60/100
Rating Breakdown:
Stock Score Analysis
Stock Score: 510
Comprehensive Quality Assessment
Component Breakdown:
Valuation Metrics
| P/E Ratio | 23.89 |
| P/B Ratio | 80.49 |
| P/S Ratio | 3.42 |
| EPS | $3.57 |
| Beta | 0.30 |
| Shares Outstanding | 806.07M |
| 52-Week High | $100.18 |
| 52-Week Low | $74.55 |
| SMA 50 | $79.87 |
| SMA 200 | $84.53 |
| Dividend Yield | 2.44% |
| Annual Dividend | $2.08 |
| Next Earnings | January 30, 2026 01:30 PM ET |
Financial Ratios
| Gross Margin | 60.2% |
| Operating Margin | 21.7% |
| Net Margin | 14.5% |
| ROE | 545.1% |
| ROA | 16.6% |
| Debt/Equity | 9.84 |
| Current Ratio | 0.93 |
| Quick Ratio | 0.60 |
Balance Sheet
| Total Assets | $16.05B |
| Total Liabilities | $15.50B |
| Total Equity | $212.00M |
|
|
|
| Cash | $1.10B |
| Total Debt | $8.51B |
| Net Debt | $7.42B |
Income Statement
| Revenue | $20.10B |
| Gross Profit | $12.11B |
| Operating Income | $4.38B |
| Net Income | $2.89B |
|
|
|
| EBITDA | $4.85B |
| Revenue/Share | $24.88 |
Cash Flow
| Operating CF | $4.11B |
| CapEx | $561.00M |
| Free Cash Flow | $3.55B |
|
|
|
| Book Value/Share | $1.53 |
| Tangible Book/Share | $-5.39 |
| Equity/Share | $1.06 |
Technical Indicators
| RSI (14) | 50.00 Neutral |
| MACD |
0.00
Signal: 0.00
|
| Volatility | 0.00% |
| Trading Signal | Neutral |
Performance & Returns
Insufficient historical data
Insufficient historical data (need 200+ days, have 0)Sector Comparison (Consumer Defensive)
| Metric | CL | Sector Avg | Percentile |
|---|---|---|---|
| P/E Ratio | 23.89 | 17.09 | 55% |
| P/B Ratio | 80.49 | -17.36 | 97% |
| ROE (%) | 545.15% | 41.65% | 94% |
| Net Margin (%) | 14.47% | 6.64% | 81% |
| Stock Score | 510 | 428.0 | 84% |
Technical Analysis
| Ticker | Close | SMA 5 | SMA 8 | SMA 13 | SMA 50 | SMA 200 | RSI (14) | MACD | Volatility (%) | Volume | Signal | SMA Decision |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CL | $85.29 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | 50.00 | 0.00 | 0.00% | 0 | Neutral | Mixed |
Candlestick Patterns
There wasn't any recognizable pattern for the CL stock
News Sentiment
| 📊 Ticker | 📰 Headline | 💭 Sentiment | 📡 Source | 🔗 URL |
|---|---|---|---|---|
| CL | Best Dividend Kings: January 2026 | Neutral | seekingalpha.com | Read More |
| CL | Colgate's Q4 Earnings Around the Corner: What Investors Should Know? | Neutral | zacks.com | Read More |
| CL | Colgate-Palmolive (CL) Reports Next Week: What You Should Expect | Neutral | zacks.com | Read More |
| CL | WESTBOURNE INVESTMENTS, INC. Sells 3,155 Shares of Colgate-Palmolive Co (CL) | Neutral | gurufocus.com | Read More |
| CL | OFI INVEST ASSET MANAGEMENT Buys 501,185 Shares of Colgate-Palmolive Co (CL) | Neutral | gurufocus.com | Read More |
Recent Insider Trading
No recent insider trading data available for CL
Company Information
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
| CEO | Noel R. Wallace |
| Employees | 34000 |
| Country | US |
| IPO Date | 1973-05-02 |
| Exchange | NYSE |
| Website | https://www.colgatepalmolive.com |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
Similar Stocks (Consumer Defensive - Household & Personal Products)
Rating Metrics Explained
DCF Score (Discounted Cash Flow)
Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.
ROE Score (Return on Equity)
Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.
ROA Score (Return on Assets)
Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.
D/E Score (Debt-to-Equity)
Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.
P/E Score (Price-to-Earnings)
Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.
P/B Score (Price-to-Book)
Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.
Rating Recommendations:
Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:
-
Strong Buy (5/5): Excellent score - strong positive indicator
- The metric significantly outperforms industry averages (top 20% of companies)
- Indicates exceptional financial health or attractive valuation in that category
-
Buy (4/5): Good score - positive indicator
- Above-average performance (top 40% of companies)
- Shows strong fundamentals with room for improvement
-
Neutral (3/5): Average score - neutral indicator
- Performance in line with industry median (middle 20%)
- Neither significantly positive nor negative signal
-
Sell (2/5): Below average - negative indicator
- Below-average performance (bottom 40% of companies)
- Suggests weakness in this particular metric
-
Strong Sell (1/5): Poor score - strong negative indicator
- Significantly underperforms industry (bottom 20%)
- Indicates potential risk or overvaluation in that category